What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa?
| dc.contributor.author | Moodley, Keymanthri | |
| dc.contributor.author | Rossouw, Theresa M. | |
| dc.date.accessioned | 2021-06-18T13:34:14Z | |
| dc.date.available | 2021-06-18T13:34:14Z | |
| dc.date.issued | 2021-02 | |
| dc.description.abstract | An efficacious COVID-19 vaccine would undoubtedly be a global public good that, in the context of a pandemic, is urgently and synchronously required by the global community. These unique features make allocation of an approved COVID-19 vaccine challenging both globally and nationally. | en_ZA |
| dc.description.department | Immunology | en_ZA |
| dc.description.librarian | am2021 | en_ZA |
| dc.description.uri | https://www.thelancet.com/journals/langlo/home | en_ZA |
| dc.identifier.citation | Moodley, K. & Rossouw, T. 2021, 'What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa?', Lancet Global Health, vol. 9, pp. E106-E107, doi : 10.1016/ S2214-109X(20)30474-5. | en_ZA |
| dc.identifier.issn | 2214-109X (online) | |
| dc.identifier.other | 10.1016/ S2214-109X(20)30474-5 | |
| dc.identifier.uri | http://hdl.handle.net/2263/80377 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | Elsevier | en_ZA |
| dc.rights | © 2020 The Author(s). This is an Open Access article under the CC BY-NC-ND 4.0 license. | en_ZA |
| dc.subject | Fair allocation | en_ZA |
| dc.subject | Efficacious | en_ZA |
| dc.subject | Vaccine | en_ZA |
| dc.subject | COVID-19 pandemic | en_ZA |
| dc.subject | Coronavirus disease 2019 (COVID-19) | en_ZA |
| dc.subject | South Africa (SA) | en_ZA |
| dc.title | What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa? | en_ZA |
| dc.type | Article | en_ZA |